Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors

Liver Transplantation

Volumn 18, Issue 1, 2012, Pages 100-111

  Taner, C Burcin ^a   Bulatao, Ilynn G ^a   Willingham, Darrin L ^a   Perry, Dana K ^a   Sibulesky, Lena ^a   Pungpapong, Surakit ^a   Aranda Michel, Jaime ^a   Keaveny, Andrew P ^a   Kramer, David J ^a   Nguyen, Justin H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTERY THROMBOSIS; ARTICLE; BILE DUCT DISEASE; BRAIN DEATH; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HUMAN; ISCHEMIC CHOLANGIOPATHY; LIVER ARTERY THROMBOSIS; LIVER GRAFT REJECTION; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; ADOLESCENT; AGED; BILIARY TRACT DISEASE; COMPARATIVE STUDY; DEATH; DONOR; LIVER; LIVER DISEASE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NECROSIS; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT DISEASES; BRAIN DEATH; DEATH; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; YOUNG ADULT;

EID: 84255162280     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22404     Document Type: Article

References (24)

1. Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO,. Organ donation and utilization in the United States, 1999-2008. Am J Transplant 2010; 10 (pt 2): 973-986.
2. Renz JF,. Is DCD for liver transplantation DNR? Am J Transplant 2008; 8: 485-488. (Pubitemid 351287543)
3. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL,. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006; 244: 555-562.
4. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM,. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010; 10: 2512-2519.
5. Jay CL, Lyuksemburg V, Kang R, Preczewski L, Stroupe K, Holl JL, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg 2010; 251: 743-748.
6. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005; 242: 724-731. (Pubitemid 41567129)
7. Selck FW, Grossman EB, Ratner LE, Renz JF,. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg 2008; 248: 599-607.
8. Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg V, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery 2009; 146: 543-552.
9. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl 2009; 15: 1028-1035.
10. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, et al. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl 2011; 17: 641-649.
11. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D'Alessandro A, et al.; for ASTS Standards on Organ Transplantation Committee. ASTS recommended guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9: 2004-2011.
12. Potts JT, Herdman R,. Non-Heart-Beating Organ Transplantation: Medical and Ethical Issues in Procurement. Washington, DC: National Academies Press; 1997.
13. Nguyen JH,. A technique for rapid control of distal aorta in donation after cardiac death procurements. Transpl Int 2008; 21: 186-188.
14. Sibulesky L, Nguyen JH,. Biliary tubes in liver transplantation. J Gastrointest Surg 2011; 15: 232-233.
15. Saidi RF, Bradley J, Greer D, Luskin R, O'Connor K, Delmonico F, et al. Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant 2010; 10: 2536-2540.
16. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF,. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87-92. (Pubitemid 38176377)
17. Ho KJ, Owens CD, Johnson SR, Khwaja K, Curry MP, Pavlakis M, et al. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation 2008; 85: 1588-1594.
18. de Vera ME, Lopez-Solis R, Dvorchik I, Campos S, Morris W, Demetris AJ, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009; 9: 773-781.
19. Chan EY, Olson LC, Kisthard JA, Perkins JD, Bakthavatsalam R, Halldorson JB, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008; 14: 604-610. (Pubitemid 351696270)
20. Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, D'Alessandro A,. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253: 817-825.
21. Hashimoto K, Eghtesad B, Gunasekaran G, Fujiki M, Uso TD, Quintini C, et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant 2010; 10: 2665-2672.
22. Skaro AI, Jay CL, Ladner D, Abecassis MM,. Trends in donation after cardiac death and donation after brain death-reading between the lines. Am J Transplant 2010; 10: 2390-2391.
23. Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 2005; 242: 556-563.
24. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439-450.